Leaders of our biocontainment team attended an event at the White House on Feb. 11 where President Barack Obama praised those on the front line of the Ebola crisis. The event highlighted how the U.S. government has worked with other governments, international organizations, private sector leaders and non-government partners to support a focused response to the virus.

Nebraska Medicine has one of three biocontainment units in the nation that have treated Ebola patients. Having drilled for countless hours since the unit opened in 2005, the Nebraska biocontainment team was uniquely qualified to answer the call. Watch video.

.

Most of us know Botox for its ability to hide wrinkles and frowns. But its many uses actually date back 25 years ago when it was first approved to treat crossed eyes. Today it is used to treat a number of medical conditions including tremors, cerebral palsy and chronic migraines. Read blog by neurologist Diego Torres-Russotto, MD, to learn more about this versatile drug.

Residents of West Omaha who need urology services now have the convenience of scheduling their appointments at Nebraska Medicine's Village Pointe clinic. Conditions treated include incontinence, over-active bladder, low testosterone, erectile dysfunction, kidney stones and urinary tract infections. The Village Pointe clinic is open every Tuesday from 8:30 a.m. to 4:30 p.m. in the Internal Medicine Clinic. 

To schedule an appointment, call 402-559-4292. To find a urologist, click here to visit our online Find a Physician service.

How much do you know about heart disease? You might be surprised at what you don't know. Having the right information about heart disease can provide you the knowledge you need to help prevent it. Cardiologist Shikhar Saxena, MD, debunks common myths surrounding this disease. Read blog.

The Department of Neurological Sciences at Nebraska Medicine is looking for healthy individuals ages 65 to 85 to participate in a nationwide Alzheimer’s disease prevention trial called the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4) Study. The study is testing an investigational medication that may prevent memory loss due to Alzheimer’s disease in persons at increased risk based on the results of a specialized amyloid brain scan. Study participants must be physically healthy, cognitively normal, and have a study partner. Neurologist Daniel Murman, MD, is leading the study at Nebraska Medicine and is screening potential candidates. (IRB# 038-14-FB)

For more information, please call 402-552-6241. To learn more about the A4 study, click here.

Healthy, easy and delicious!  You'll like this one better than take-out. Click here for recipe.